Voreloxin
CAS: 175414-77-4
Ref. 3D-AHA41477
| 1mg | 188.00 € | ||
| 2mg | 300.00 € | ||
| 5mg | 470.00 € | ||
| 10mg | 704.00 € | ||
| 25mg | 1,052.00 € |
Product Information
- 1,4-Dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid
- 1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-
- 1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-7-[3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-, (3S-trans)-
- Ag-7352
- Sns-595
- Spc-595
- Vosaroxin
Voreloxin is a topoisomerase inhibitor that binds to the enzyme's active site, preventing it from breaking and rejoining DNA. Voreloxin has been shown to be minimally toxic in pre-clinical models of acute myeloid leukemia. It inhibits the activity of deoxyribonucleic acid (DNA) methyltransferases, which are enzymes that control DNA methylation and gene expression. Voreloxin is also an effective inhibitor against dna methyltransferase inhibitors, which are drugs used in chemotherapy for cancer treatment. Side-effects of voreloxin are minimal and include myeloid leukemia in animal models. Voreloxin has not been tested against other types of cancers.
Chemical properties
Technical inquiry about: 3D-AHA41477 Voreloxin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
